Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
Titel:
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
Auteur:
Paz-Ares, Luis G. Pérol, Maurice Ciuleanu, Tudor-Eliade Kowalyszyn, Ruben Dario Reck, Martin Lewanski, Conrad R. Syrigos, Konstantinos Arrieta, Oscar Prabhash, Kumar Park, Keunchil Pikiel, Joanna Göksel, Tuncay Lee, Pablo Zimmermann, Anna Carter, Gebra Cuyun Alexandris, Ekaterine Garon, Edward B.